Strategic Analysis of Maryland Tax – General Code Section § 10-721: Legal Architecture and Administrative Execution of the Research and Development Tax Credit

Maryland Tax – General Code Section § 10-721 establishes the legal authority for the state’s Research and Development (R&D) tax credit, providing an income tax offset for qualified research expenditures conducted within the state.1 The statute incentivizes innovation by offering a ten percent credit on Maryland-based research expenses that exceed a historically derived base amount, specifically targeting incremental growth in the state’s high-technology sectors.2

The Maryland Research and Development Tax Credit represents a sophisticated fiscal instrument designed to anchor high-growth industries—such as life sciences, cybersecurity, aerospace, and advanced manufacturing—within the state’s economic borders. Section § 10-721 of the Tax – General Article provides the foundational definitions and mechanics for this incentive, which operates through a distinct dual-agency administrative structure involving the Maryland Department of Commerce and the Comptroller of Maryland.1 Since its inception during the 2000 session of the Maryland General Assembly, the credit has evolved from a two-tiered system into a more targeted mechanism following the comprehensive legislative overhaul enacted by Senate Bill 196 in 2021.5 This statutory framework is inextricably linked to Federal standards, as Section § 10-721 explicitly incorporates the definitions of qualified research and expenses found in Section 41 of the Internal Revenue Code (IRC).1 Consequently, the application of the Maryland credit requires a nuanced understanding of both state-specific administrative procedures and the rigorous technical requirements of federal tax law. The program’s complexity is further heightened by the chronic oversubscription of its annual $12 million funding cap, which necessitates a proportional proration of certified credits among all eligible applicants.2 This analysis explores the statutory nuances, calculation methodologies, administrative guidance, and economic implications of Section § 10-721, providing a comprehensive roadmap for professional practitioners and business leaders navigating Maryland’s innovation incentives.

Statutory Definitions and the Federal Nexus

The structural integrity of Section § 10-721 rests upon its alignment with the Internal Revenue Code, a mechanism known as conformity that simplifies compliance for multi-state entities while allowing Maryland to leverage federal audit standards. Subsection (a) of the statute defines the critical terms that govern eligibility and the scope of the incentive.1

The Incorporation of IRC Section 41 Standards

The most significant provision within the definitions section is the explicit adoption of federal definitions for research activities and expenditures. Under § 10-721(a)(5) and (6), “Maryland qualified research and development” and “Maryland qualified research and development expenses” are defined as activities and costs that meet the criteria set forth in IRC § 41(d) and § 41(b), respectively, provided that the underlying research is conducted within the physical boundaries of Maryland.1 This incorporation by reference means that a business must first satisfy the federal “Four-Part Test” to be considered for the Maryland credit.8

The Four-Part Test requires that the research activity be technological in nature, relying on principles of physical or biological sciences, engineering, or computer science.8 Furthermore, the activity must relate to a “permitted purpose,” defined as the development of a new or improved business component’s function, performance, reliability, or quality.8 The taxpayer must also demonstrate the “elimination of uncertainty” regarding the development or improvement of the product or process and engage in a “process of experimentation” that involves the systematic evaluation of alternatives.8 By tethering the state credit to these federal pillars, Section § 10-721 ensures that only legitimate, high-level scientific and technical endeavors receive state subsidies, rather than routine quality control or aesthetic improvements.8

Distinguishing the Department and the Comptroller

Section § 10-721(a)(2) identifies the “Department” as the Maryland Department of Commerce.1 This designation is vital because the R&D tax credit is not a self-executing credit that a taxpayer can simply claim on an initial return.1 Instead, the statute mandates a certification process where the Department of Commerce evaluates applications and allocates the finite pool of $12 million in available credits.2 Once the Department issues a certification letter, the taxpayer must then interact with the Comptroller of Maryland to apply the credit against their tax liability.4 The Comptroller’s role is primarily focused on the revenue administration aspect, including the processing of amended returns and the enforcement of the “addition modification” required under Tax – General § 10-205.18

Legislative Evolution and the Impact of Senate Bill 196

The current state of Section § 10-721 is the result of decades of legislative refinement, with the most profound changes occurring in the 2021 session. Before this overhaul, the Maryland R&D credit was a two-component program consisting of a “Basic” credit and a “Growth” credit.5

The Repeal of the Basic Research and Development Credit

Historically, the Basic R&D credit allowed businesses to claim a 3% credit on qualified research expenses that did not exceed the Maryland base amount.3 This was essentially a reward for maintaining a baseline level of research activity. However, an evaluation conducted by the Department of Legislative Services (DLS) found that this component frequently provided “windfall” benefits for activities that would have occurred regardless of the incentive.6

Consequently, Senate Bill 196 (Chapter 114, Acts of 2021) repealed the Basic credit effective for tax years beginning after December 31, 2019.3 By eliminating the 3% Basic credit, the General Assembly shifted all available funding to the Growth R&D credit, which provides a more robust 10% credit for expenses that exceed the Maryland base amount.2 This legislative shift reflects a strategic pivot toward incentivizing incremental investment and scaling innovation rather than subsidizing existing operations.6

Funding Caps and the Small Business Set-Aside

In addition to streamlining the credit types, Senate Bill 196 significantly altered the funding architecture of the program. The annual aggregate cap was increased to $12 million to provide a more meaningful incentive to the state’s expanding tech sector.2 To prevent a small number of large multinational corporations from consuming the entire allocation, the legislature established a mandatory set-aside for small businesses.2

The statute also includes a reallocation provision: if the total applications from small businesses are less than $3.5 million, the remaining funds can be shifted to the general business bucket to maximize the use of the state’s allocation.2 Conversely, the program is almost always oversubscribed, meaning that most businesses receive a prorated portion of the 10% credit they applied for.2

Technical Calculation of the Maryland Base Amount

Central to the application of Section § 10-721 is the calculation of the “Maryland Base Amount,” a threshold that distinguishes between routine research spending and the “growth” spending that qualifies for the credit. The statute defines this base amount by adapting the federal formulas under IRC § 41(c) to state-specific data.1

The Rolling Four-Year Average and Fixed-Base Percentage

The calculation of the Maryland base amount requires a taxpayer to analyze their historical Maryland-sourced data for the four taxable years preceding the credit year.2 The two primary variables are Maryland Qualified Research Expenses (MD QREs) and Maryland Gross Receipts.1

The process begins with determining the “Fixed-Base Percentage” (FBP), which represents the historical intensity of the company’s research relative to its revenue.1 The FBP is computed by dividing the aggregate MD QREs for the prior four years by the aggregate Maryland gross receipts for those same years.1 Under federal guidelines incorporated by the state, the FBP is generally capped at 16% to ensure the base amount does not become an insurmountable hurdle for high-growth firms.9

$$\text{Fixed-Base Percentage (FBP)} = \frac{\sum \text{MD QREs (Prior 4 Years)}}{\sum \text{MD Gross Receipts (Prior 4 Years)}}$$

1

Once the FBP is established, the Maryland Base Amount is determined by multiplying the FBP by the average annual Maryland gross receipts for the preceding four years.2

$$\text{Maryland Base Amount} = \text{FBP} \times \text{Average MD Gross Receipts (Prior 4 Years)}$$

2

The 50% Minimum Base Amount Rule

A critical safeguard found in IRC § 41(c)(2), and applied to the Maryland credit through § 10-721, is the 50% minimum base amount rule.9 This rule mandates that in no event shall the base amount be less than 50% of the qualified research expenses for the credit year.9 This ensures that even a company with extremely low historical research spending cannot claim a credit on more than half of its current year research budget.13

$$\text{Final Base Amount} = \max\left(\text{Calculated Base Amount}, 0.50 \times \text{Current MD QRE}\right)$$

9

For startups and “first-year” research firms that have no historical MD QREs, the statute allows for a base amount of zero, enabling them to claim the 10% credit on their entire initial research expenditure, subject to the overall program caps and proration.2

Small Business Provisions and the Refundability Mechanism

Maryland’s R&D tax credit program is particularly advantageous for small businesses, offering a level of liquidity that is rare in state tax incentives. Section § 10-721(d) provides the statutory basis for making the credit refundable for entities that meet specific asset criteria.1

Defining the Small Business Threshold

To qualify for the $3.5 million set-aside and the refundability feature, a business must meet the statutory definition of a “small business.” Under the 2021 amendments, this is defined as a for-profit entity with “net book value assets” totaling less than $5,000,000 at either the beginning or the end of the taxable year in which the Maryland QREs are incurred.2

The legislation provided much-needed clarity on the term “net book value assets,” defining it as the total net value of assets—including intangibles such as patents and software—minus liabilities, and further reduced by accumulated depreciation and amortization.6 This calculation must align with the business’s balance sheet as reported for financial or tax purposes.2 This definition is strategically significant for early-stage life science companies that may have valuable intellectual property but limited physical assets or high levels of debt, allowing them to remain eligible for the small business benefits during their most capital-intensive phases.3

The Power of Refundability for Startups

For a standard corporation or individual, a tax credit is non-refundable, meaning it can only be used to reduce tax liability to zero. Any excess credit must be carried forward to future years.2 However, for certified small businesses, the R&D credit is fully refundable to the extent it exceeds the state income tax liability for the year.2

This means a pre-revenue startup with no tax liability can receive a direct payment from the state treasury for the full amount of its certified credit.3 In an industry like biotechnology, where companies may conduct research for a decade before bringing a product to market, this refundability serves as a critical source of non-dilutive funding that can be used to sustain operations and hire additional research staff.3

Administrative Procedures: The Path from Application to Claim

The administrative life cycle of a Maryland R&D credit claim is governed by strict timelines and documentation requirements set by the Department of Commerce and the Comptroller’s Revenue Administration Division.

The Department of Commerce Certification Process

Participation in the program begins with an annual application submitted to the Department of Commerce by November 15 of the calendar year following the year in which the expenses were incurred.2 For example, expenses incurred during the 2024 tax year must be reported to the Department by November 15, 2025.2

The application requires detailed financial data, including:

• Maryland gross receipts for the prior four years.2
• Maryland qualified research expenses for the prior four years and the current year.2
• Documentation of small business status, if applicable, including balance sheets.2
• Proof of “Good Standing” with the State Department of Assessments and Taxation (SDAT).4
• A copy of Federal Form 6765 if the federal credit was also claimed.4

The Department reviews all applications and issues a certification letter by February 15 of the subsequent year (e.g., February 15, 2026, for 2024 expenses).14 This letter specifies the exact amount of the credit the business is authorized to claim, after accounting for any necessary proration due to oversubscription.2

The Role of the Comptroller and the § 10-205 Add-Back

Once the certification is received, the taxpayer must file an income tax return with the Comptroller. Because the certification letter is typically issued after the deadline for original tax returns, most businesses claim the R&D credit by filing an amended Maryland return for the year in which the expenses were incurred.1

A unique and mandatory requirement of the Maryland credit is the “addition modification” found in Tax – General § 10-205(i).18 To prevent a taxpayer from receiving both a state deduction and a state credit for the same expenses, Maryland law requires the taxpayer to add the amount of the R&D credit claimed back to their federal adjusted gross income (for individuals) or federal taxable income (for corporations) to determine their Maryland taxable income.18

For pass-through entities (PTEs) such as S-corporations or LLCs, the entity earns the credit and passes it through to its shareholders or members.1 Each individual member must then report their pro-rata share of the credit and the corresponding addition modification on their personal Maryland income tax return.18

Oversubscription and the Proration Reality

Despite the statutory 10% rate mentioned in Section § 10-721, the actual benefit realized by Maryland taxpayers is often significantly lower due to the program’s immense popularity and its fixed $12 million funding cap.2

The Mechanics of Proration

When the total amount of credits applied for in a given year exceeds the statutory limit, the Department of Commerce is required by § 10-721(c) to prorate the awards.2 The proration is calculated separately for the small business bucket ($3.5M) and the general business bucket ($8.5M).2

The Department calculates a fraction where the numerator is the available statutory funding and the denominator is the total amount of qualified credits applied for by all businesses in that category.2 Each applicant’s potential 10% credit is then multiplied by this fraction to determine their final certified amount.2

Historical Data on Proration Trends

Data from the Department of Commerce and the Department of Legislative Services reveals a consistent pattern of extreme oversubscription, particularly before the 2021 overhaul consolidated the program.5

The 2024 DLS evaluation observed that while the 2021 changes helped mitigate some of the “windfall” effects, businesses still receive unequal credit rates compared to the statutory goal because the proration process effectively turns a 10% credit into a ~1.5% incentive.10 For large corporations, this may lead to the credit being viewed as a compliance exercise rather than a primary driver for new Maryland-based investment.10

Comprehensive Example: The Growth Credit Calculation

To visualize the application of Section § 10-721 in a corporate setting, consider “AeroDefense MD,” a manufacturing firm specializing in carbon-composite rocket components.2

Current Year (2024) Profile:

• Maryland Qualified Research Expenses: $5,000,000.
• Maryland Gross Receipts: $50,000,000.
• Total Net Book Value Assets: $25,000,000 (Non-Small Business).2

Historical Averages (2020-2023):

• Total Maryland QREs: $16,000,000.
• Total Maryland Gross Receipts: $160,000,000.

Step 1: Calculate the Fixed-Base Percentage (FBP)

$$FBP = \frac{\$16,000,000}{\$160,000,000} = 0.10 \text{ or } 10\%$$

1

Step 2: Calculate the Maryland Base Amount

$$\text{Average Receipts} = \frac{\$160,000,000}{4} = \$40,000,000$$

$$\text{Calculated Base Amount} = 0.10 \times \$40,000,000 = \$4,000,000$$

2

Step 3: Apply the 50% Minimum Rule

$$\text{Minimum Base Amount} = 0.50 \times \$5,000,000 = \$2,500,000$$

Since the calculated base ($4M) is greater than the minimum base ($2.5M), the Maryland Base Amount is $4,000,000.9

Step 4: Calculate the Potential 10% Credit

$$\text{Growth Amount} = \$5,000,000 – \$4,000,000 = \$1,000,000$$

$$\text{Potential Credit} = \$1,000,000 \times 0.10 = \$100,000$$

2

Step 5: Apply the Proration (Assuming 2023 trends)

If the non-small business bucket is oversubscribed such that only 15.4% of requested credits are funded:

$$\text{Final Certified Credit} = \$100,000 \times 0.154 = \$15,400$$

2

AeroDefense MD would receive a certification letter for $15,400, which they would claim on an amended 2024 Form 500 while adding $15,400 back to their taxable income.1

Compliance, Audit Defense, and Controlled Groups

Because Section § 10-721 relies so heavily on federal definitions, it is a high-priority area for state auditors who often coordinate with federal findings or conduct their own verification of “qualified activities”.8

Substantiating Qualified Research Activities (QRAs)

To survive an audit, a business must maintain contemporaneous records that prove the research occurred in Maryland and met the four-part test.14 Documentation should include:

• Project Lists and Technical Reports: Descriptions of the scientific or technical objectives and the uncertainties involved in each project.8
• Innovation Logs: Records of trials, errors, bug fixes, and photographs or videos of testing protocols.14
• Labor Time Sheets: Precise records showing how much time employees spent on research vs. administrative or production tasks.14
• Vendor Contracts: For “Contract Research Expenses” (limited to 65% of actual cost), documentation must prove the taxpayer bore the economic risk and retained the rights to the research.4

The Controlled Group and Aggregation Rules

Under Section § 10-721(e) and federal IRC § 41(f), all members of a “controlled group” of corporations or businesses under common control are treated as a single taxpayer.1 Common control exists when two or more entities share more than 50% common ownership.15

In these cases:

• The entire group’s Maryland QREs and gross receipts are aggregated to calculate a single group-wide credit.8
• This prevents companies from shifting high-research expenses to a subsidiary with low gross receipts to artificially inflate the growth credit.15
• The final certified credit is then allocated back to each individual member based on their proportionate share of the group’s total QREs.15

Mergers, Acquisitions, and Credit Carryforwards

Corporate transitions introduce significant complexity into the § 10-721 calculation, particularly regarding the continuity of the “base amount” and the survival of credit carryforwards.

Treatment of Carryforwards and Refunds

For large businesses that earn a non-refundable credit, Section § 10-721 allows any unused portion of the credit to be carried forward for up to seven years.2 The credit cannot be carried back to prior years.14 If a business is acquired in a stock purchase, these carryforwards typically remain with the legal entity and can be used to offset the future tax liability of the combined group.2 In an asset purchase, however, the credit carryforwards usually stay with the selling entity unless explicitly transferred or if the selling entity ceases to exist in a manner that allows for the transfer of tax attributes under state law.2

Recomputing the Base After Acquisition

When a company acquires another entity, it must adjust its historical base data to include the QREs and gross receipts of the acquired firm.2 This prevents an acquiring company from showing a massive “growth” in research spending simply because it merged with another research-heavy organization.20 Conversely, if a business disposes of a division, it must reduce its historical base by the research spending and revenue associated with that division.1

Economic Evaluation and Future Outlook

The 2024 evaluation of the R&D tax credit program by the Department of Legislative Services provided a critical perspective on the program’s effectiveness compared to national trends.10

Maryland Activity vs. National Growth

While the R&D credit is widely used by Maryland businesses, the DLS report noted that between 2015 and 2021, business-funded R&D in Maryland increased by 61%, while the national average grew by 84%.10 This suggests that while the credit is a helpful subsidy, it has not necessarily caused Maryland to outperform states without such credits or with different incentive structures.6 The report concluded that factors such as a highly skilled workforce, proximity to federal agencies (NIH, NASA, NIST), and university partnerships are more significant drivers of innovation than the $12 million annual credit.6

The 2027 Sunset Provision

Section § 10-721 is currently set to expire on June 30, 2027.1 This “sunset” clause forces the General Assembly to periodically re-evaluate the program’s fiscal impact and effectiveness. Given the recent 2024 DLS evaluation, future legislative sessions may consider additional alterations, such as:

• Increasing the $12 million cap to reduce proration and increase the effective credit rate.3
• Targeting specific industries more precisely (e.g., green energy or quantum computing).27
• Simplifying the application process to reduce the administrative burden on small businesses.6

Conclusion

Maryland Tax – General Code Section § 10-721 stands as a cornerstone of the state’s economic development strategy, successfully balancing the needs of established corporations with the capital requirements of emerging startups. By tethering state incentives to the rigorous technical standards of IRC § 41, the statute ensures that state funds are directed toward genuine technological advancement. The 2021 legislative shift to an incremental growth model has sharpened the program’s focus, while the $3.5 million small business set-aside and refundability provisions provide a vital lifeline for Maryland’s innovation ecosystem.

However, the reality of chronic oversubscription means that businesses must view the credit through a pragmatic lens, recognizing that the effective benefit is often a fraction of the nominal 10% rate. Success in leveraging § 10-721 requires a commitment to meticulous recordkeeping, a proactive approach to the annual November 15 application deadline, and a sophisticated understanding of the interaction between the Department of Commerce’s certification and the Comptroller’s revenue rules. As Maryland looks toward the 2027 sunset of the program, Section § 10-721 will likely remain a subject of intense policy debate, reflecting the state’s ongoing efforts to maintain its position as a national leader in the global innovation economy.

R&D Tax Credit Preparation Services

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.

If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.

R&D Tax Credit Audit Advisory Services

creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.

Our Fees

Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/